Fran├žoise Baylis

is University Research Professor at Dalhousie University. She is a member of the Order of Canada and the Order of Nova Scotia, as well as a Fellow of the Royal Society of Canada and a Fellow of the Canadian Academy of Health Sciences. In 2017 she was awarded the Canadian Bioethics Society Lifetime Achievement Award.

Baylis is a philosopher whose innovative work in bioethics, at the intersection of policy and practice, has stretched the boundaries of the field. Her work challenges us to think broadly and deeply about the direction of health, science and biotechnology. It aims to move the limits of mainstream bioethics and develop more effective ways to understand and tackle public policy challenges.

A public intellectual for the modern age, Baylis brings her ethical sensibilities, informed by best practices, theory and common sense, to a wide range of public issues. Her current research focuses on human genome modification, assisted human reproduction, research involving women, and COVID-19.

Baylis is the author of Altered Inheritance: CRISPR and the Ethics of Human Genome Editing. She is a member of the Governing Board of the International Science Council, a member of the Planning Committee for the Third International Summit on Human Genome Editing to be held in London in March 2022, and a member of the WHO Working Group on Principles of the Global Guidance Framework for the Responsible Use of the Life Sciences.